4 cycles of TC (docetaxel + cyclophosphamide) adjuvant chemotherapy

DRUG2 trials

Sponsors

Fudan University

Conditions

Breast Cancer

Phase 2

ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer

Not yet recruitingNCT07423611

Fudan UniversityBreast Cancer

Start: 2026-10-01End: 2030-12-31Target: 388Updated: 2026-02-20

Phase 3

Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor

Not yet recruitingNCT06996093

Fudan UniversityBreast Cancer

Start: 2025-06-02End: 2034-06-01Target: 2508Updated: 2025-05-30